Pregnant women with covid-19 are at greater risk of severe disease than their non-pregnant
peers, and yet they are frequently denied investigations or treatments because of unfounded …

The SARS-CoV-2 pandemic has had a significant impact worldwide, particularly in middle-
and low-income countries. While this impact has been well-recognized in certain age …

Background Prenatal maternal physiological changes may cause severe COVID-19 among
pregnant women. The Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA) has been …

Pregnant and lactating women (PLW) represent a particular population subset with
increased susceptibility for COVID-19 morbidity and mortality, even though the evidence …

Importance Pregnant women are recommended to receive COVID-19 vaccination to reduce
risk of severe COVID-19. Whether vaccination during pregnancy also provides passive …

BACKGROUND The exclusion of pregnant women from initial COVID-19 messenger RNA
vaccine trials raised hesitancy regarding the benefits of vaccination for pregnant women …

Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious immune-
mediated condition, seen 3–5 weeks after COVID-19. Maternal SARS-CoV-2 may potentially …

Substantial immunological changes occur throughout pregnancy to render the mother
immunologically tolerant to the fetus and allow fetal growth. However, additional local and …

Резюме В статье приведен обзор литературы, посвященный инновационным
методикам лечения ран мягких тканей. Определены наиболее эффективные …

Despite extensive studies into severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the effect of maternal infection on the neonate is unclear. To investigate this, we …